Regenerative medicine in rotator cuff injuries

Area of Science:

• Orthopedics and Sports Medicine
• Regenerative Medicine
• Biotechnology

Background:

• Rotator cuff injuries are prevalent, causing significant disability and often yielding suboptimal results with surgical treatment.
• Tissue engineering strategies, including growth factors and cell-based therapies, are emerging as promising alternatives for tendon regeneration.
• Platelet-rich plasma (PRP) and mesenchymal stem cells (MSCs) are key components in these novel regenerative approaches.

Purpose of the Study:

• To review current tissue engineering strategies for rotator cuff tendon regeneration.
• To evaluate the potential of growth factors, such as PRP, and cell-based therapies, including MSCs, in enhancing rotator cuff healing.
• To highlight the need for further research in stem cell therapies for rotator cuff disease.

Main Methods:

• Review of in vitro and animal studies on growth factor effects on tendon healing.
• Analysis of clinical studies on autologous platelet-rich plasma (PRP) formulations.
• Investigation of ex vivo studies isolating mesenchymal stem cells (MSCs) from various shoulder tissues.

Main Results:

• Growth factors show promising results in promoting tendon healing in preclinical models.
• Clinical studies on PRP for rotator cuff tears yield controversial results, though favorable structural healing is noted for smaller tears.
• Mesenchymal stem cells (MSCs) have been successfully isolated from rotator cuff tendons and surrounding tissues, indicating potential for cell-based therapies.

Conclusions:

• Tissue engineering, utilizing growth factors and stem cells, represents a novel frontier for managing rotator cuff injuries.
• While PRP shows some promise, its clinical efficacy remains debated.
• Further basic and clinical research is essential to fully realize the potential of stem cell therapies in treating rotator cuff disease.